William L. Welbourn

Robust computational tools for multiple testing with genetic association studies

William L. Welbourn, 2012 .

PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer

William L. Welbourn, J. Reid, S. Freedland, 2014, International journal of urology : official journal of the Japanese Urological Association.

Prognostic utility of CCP score in men with prostate cancer after primary external beam radiation therapy.

William L. Welbourn, A. Gutin, J. Reid, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigating Genetic Markers Associated with Venous Thromboembolism: A Genome Wide Association Study (GWAS)

William L. Welbourn, 2009 .

Use of the cell cycle progression (CCP) score for predicting systemic disease and response to radiation of biochemical recurrence.

William L. Welbourn, J. Reid, Liang Cheng, 2016, Cancer biomarkers : section A of Disease markers.

PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival

William L. Welbourn, K. Shokat, C. Atreya, 2013, Cancer medicine.

Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy.

William L. Welbourn, J. Bishoff, G. Sauter, 2014, The Journal of urology.

Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy.

William L. Welbourn, A. Gutin, J. Reid, 2013, International journal of radiation oncology, biology, physics.

Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer

William L. Welbourn, M. Lucia, M. Brawer, 2014, Current medical research and opinion.

Prognostic utility of CCP score in men with prostate cancer after primary external beam radiation therapy.

William L. Welbourn, A. Gutin, J. Reid, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.